Increased reporting of adverse reactions to ACE inhibitors associated with limitations to drug reimbursement for angiotensin-II receptor antagonists.
- 1 September 2001
- journal article
- pharmacoepidemiology and-prescription
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 57 (6) , 509-512
- https://doi.org/10.1007/s002280100336
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: